Cargando…
Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy
BACKGROUND: Alzheimer Disease (AD) and cerebral amyloid angiopathy (CAA) are both characterized by amyloid-β (Aβ) accumulation in the brain, although Aβ deposits mostly in the brain parenchyma in AD and in the cerebrovasculature in CAA. The presence of CAA can exacerbate clinical outcomes of AD pati...
Autores principales: | Xiong, Monica, Wang, Chao, Gratuze, Maud, Saadi, Fareeha, Bao, Xin, Bosch, Megan E., Lee, Choonghee, Jiang, Hong, Serrano, Javier Remolina, Gonzales, Ernesto R., Kipnis, Michal, Holtzman, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018855/ https://www.ncbi.nlm.nih.gov/pubmed/36922879 http://dx.doi.org/10.1186/s13024-023-00610-x |
Ejemplares similares
-
Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration
por: Drieu, Antoine, et al.
Publicado: (2023) -
Cerebrovascular Reactivity Across the Entire Brain in Cerebral Amyloid Angiopathy
por: Beaudin, Andrew E., et al.
Publicado: (2022) -
Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
por: Camacho, Jessica, et al.
Publicado: (2019) -
The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy
por: Morris, Alan W. J., et al.
Publicado: (2014) -
Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?
por: Wagner, Andrea, et al.
Publicado: (2021)